Epidemiology of acute coronary syndrome and heart failure in Latin America;Epidemiología del síndrome coronario agudo y la insuficiencia cardiaca en Latinoamérica

Revista Espanola de Cardiologia

Volumn 64, Issue SUPPL. 2, 2011, Pages 34-43

  Hernández Leiva, Edgar ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Acute coronary syndrome; Cardiovascular disease; Epidemiology; Heart failure; Latin America

Indexed keywords

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; CHAGAS DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; HEART FAILURE; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; OBESITY; REVIEW; SOUTH AND CENTRAL AMERICA;

EID: 79961112865     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.01.022     Document Type: Article

References (49)

1. Gaziano T, Reddy S, Paccaud F, Horton S, Chaturvedi V. Cardiovascular disease. En: Disease control priorities in developing countries. 2.a ed. Oxford: Oxford University Press and The World Bank; 2006. p. 645-62.
2. American Heart Association. International Cardiovascular Disease Statistics [serie en internet]. Disponible en: http://www.sld.cu/galerias/pdf/ servicios/hta/international-cardiovascular-disease-statistics.pdf
3. Gaziano T. Cardiovascular disease in the developing world and its cost-effective management. Cardiologyrounds [serie en internet]. 2005;9 (2). Disponible en: http://www.cardiologyrounds.org/crus/cardious-0205.pdf
4. Roses Periago M. Situación de salud en las Américas. Indicadores básicos 2009. Disponible en: http://new.paho.org/hq/ dmdocuments/2009/IB-SPA-2009.pdf
5. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;XLIX:509-38.
6. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: The age of delayed degenerative diseases. Milbank Mem Fund Q. 1986;64:355-91. (Pubitemid 17033055)
7. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-53. (Pubitemid 33108145)
8. Reddy SK, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596-601. (Pubitemid 28090690)
9. Tunstall-Pedoe H. The WHO MONICA Project. J Clin Epidemiol. 1988;41:105-13.
10. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease study. Lancet. 1997;349:1498-504.
11. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet. 2000;355:675-87. (Pubitemid 30107623)
12. The WHO Statistical Information System (the WHOSIS), 2003. Disponible en: http://www3.who.int/whosis/menu.cfm
13. 2003 World Development Indicators CD-ROM, World Bank. Disponible en: http://devdata.worldbank.org/hnpstats/deaselection.asp
14. Sachs J. CVD status and projections in five developing countries. En: Sachs J, editor. A race against time: the challenge of cardiovascular disease in developing economies. New YorK: The Trustees of Columbia University in the City of New York; 2004.
15. Fuster V. Low priority of cardiovascular and chronic diseases on the global health: agenda: a cause for concern. Circulation. 2007;116:1966-70. (Pubitemid 350287092)
16. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American Study. Circulation. 2007;115:1067-74. (Pubitemid 46673168)
17. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM. Obesity in Latin American women and children. J Nutr. 1998;128:1464-73. (Pubitemid 28399943)
18. Barbash GI, Modan M, Goldbourt U, White HD, Van de Werf F. Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase mortality Trial: variation by country beyond predictive profile. J Am Coll Cardiol. 1993;21:281-6. (Pubitemid 23047906)
19. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA. 1995;273:1586-91.
20. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436-43.
21. O'Shea JC, Califf RM. Inter-regional differences in acute coronary syndrome trials. Eur Heart J. 2000;21:1397-9. (Pubitemid 30636317)
22. Simes RJ, O'Connell RL, Aylward PE, Varshavsky S, Diaz R, Wilcox RG, et al. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Am Heart J. 2010;159:988-97.
23. Fox KAA, Goodman S, Bigonzi F, Louer LV, Choen M. Inter-regional differences and outcome in unstable angina. Analysis of the International ESSENCE trial. Eur Heart J. 2000;21:1433-9.
24. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. N Engl J Med. 1998;339:436-43.
25. Cohen M. Latinoamérica en los ensayos clínicos internacionales: ¿Dónde está la diferencia? ¿Son los pacientes, los médicos o el sistema? Rev Argent Cardiol. 2003;71:6-15.
26. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101:2557-67.
27. Cohen MG, Pacchiana CM, Corbalan R, Pérez JE, Ponte CI, Oropeza ES, et al. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Am Heart J. 2001;141:391-401. (Pubitemid 32200267)
28. Giugliano RP, Llevadot J, Wilcox RG, Gurfinkel EP, McCabel CH, Charlesworth A, et al, for the InTIME (Intravenous nPA for Treatment of Infarcting Myocardium Early) II Investigators. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST elevation myocardial infarction treated with fibrinolysis. Results from inTIME-II. Eur Heart J. 2001:22;1702-15.
29. García-Castillo A, Jerjes-Sánchez C, Martínez P, Azpiri-López JR, Autrey A, Martínez C, et al; por los Investigadores del Registro Nacional de Síndromes Coronarios Agudos. RENASICA II. Registro Mexicano de Síndromes Coronarios Agudos. Arch Cardiol Mex. 2005;75:S6-19.
30. Fox K, Goodman G, Klein W, Brieger D, Steg PG, Dabbous O, et al; for the GRACE Investigators. Management of acute coronary syndromes. Variations in practice and outcome Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002:23;1177-89.
31. Orlandini A, Díaz R, Wojdyla D, Pieper K, Van de Werf F, Granger CB, et al. Estudios Clínicos Latino America (ECLA) Collaborative Group. Eur Heart J. 2006;27:527-33.
32. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone, et al; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics, 2010 Update: a report from the American Heart Association. Circulation. 2010;121:e46-215.
33. Ventura HO, Mehra MR. The growing burden of heart failure: The "syndemic" is reaching Latin America. Am Heart J. 2004;147:386-89.
34. Bocchi EA, Guimaraes G, Tarasoutshi F, Spina G, Mangini S, Bacal F. Cardiomyopathy, adult valve disease and heart failure in South America. Heart. 2009;95:181-9.
35. Programa de la ONU: Informe sobre Desarrollo Humano 2010. Disponible en: http://78.136.31.142/en/media/PR5-HDR10-RegRBLAC-SP.pdf
36. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, et al. Predictors of heart failure among women with coronary disease. Circulation. 2004;110:1424-30. (Pubitemid 39263737)
37. Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva LC, et al; for the CARMELA Study Investigators. CARMELA: Assessment of cardiovascular risk in seven Latin American cites. Am J Med. 2008;121:58-65.
38. Cubillos LA, Casas JP, Morillo CA, Bautista L. Congestive heart failure in Latin America: The next epidemic. Am Heart J. 2004;147:412-7. (Pubitemid 38880860)
39. WHO Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser. 2002;905:i-vi, 1-109.
40. Von AJ. Chagas disease. Infect Developing Countries. 2007;1:99-111.
41. Wilson LS, Strosberg AM, Barrio K. Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov models. Am J Trop Med Hyg. 2005;73:901-10. (Pubitemid 41688466)
42. Barreto AC, Nobre MR, Wajngarten M, Canesin MF, Ballas D, Serro-Azul JB. Insuficiencia cardiaca em grande hospital terciario de Sao Paulo. Arq Bras Cardiol. 1998;71:15-20. (Pubitemid 128519139)
43. Perna ER, Barbagelata A, Grinfeld L, Garciá B, Címbaro JP, Canella Bayol PA, et al. Overview of acute decompensated heart failure in Argentina: Lessons learned from 5 registries during the last decade. Am Heart J. 2006;151:84-91. (Pubitemid 41815335)
44. Freitas HFG, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospitalbased cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol. 2005;102:239-47. (Pubitemid 40861705)
45. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J Suppl. 2005;7 Suppl B:B13-9.
46. Guimarães PR, Chizzola G, Souza F, Issa VS, Amaral AF, Cruz S, et al. Subanalysis of the REMADHE Prospective Trial. Circ Heart Fail. 2010;3:82-8.
47. Valero E. Muerte súbita en la miocardiopatía chagásica: papel del cardiodefibrilador implantable. Relampa. 2008;21:67-83.
48. Mangini S, Silveira FS, Silva CP, Grativvol PS, Seguro LF, Ferreira SM, et al. Decompensated heart failure in the emergency department of a cardiology hospital. Arq Bras Cardiol. 2008;90:400-6.
49. Ministério da Saúde. Coordenação de Doenças Crônicas-Degenerativas. Incidência da febre reumática no Brasil. Brasília; 2003.